02339nam a2200469 a 4500003477245MiAaHDL20250726000000.0m d cr bn ---auaua000508s1992 dcua b f000 0 eng d0160395364(MiU)990034772450106381sdr-miu.990034772450106381sdr-pst.a1890080(MiU)MIU01000000000000003477245-goog(OCoLC)28101256(MiU)Aleph003477245GPOGPOVYLEYMUtOrBLWn-us---1009-C-08 (MF)1009-B-08Y 4.N 16:102-2-10SCNAC-102-2-10KF27.5.N3 1992jUnited States.Congress.House.Select Committee on Narcotics Abuse and Control.http://id.loc.gov/authorities/names/n79045319http://id.loc.gov/rwo/agents/n79045319Pill mills, Medicaid fraud, and the diversion of pharmaceuticals :hearing before the Select Committee on Narcotics Abuse and Control, House of Representatives, One Hundred Second Congress, second session, July 29, 1992.Washington :U.S. G.P.O. :For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,1992.iii, 107 p. :ill. ;23 cmtexttxtrdacontentunmediatednrdamediavolumencrdacarrier"SCNAC-102-2-10."Shipping list no.: 93-0225-P.Distributed to some depository libraries in microfiche.Includes bibliographical references.Mode of access: Internet.Substance-Related Disordersprevention & control.http://id.nlm.nih.gov/mesh/D019966Q000517Fraud.http://id.nlm.nih.gov/mesh/D005607Medicaid.http://id.nlm.nih.gov/mesh/D008484Drug abuseUnited StatesPrevention.http://id.loc.gov/authorities/subjects/sh2008102430Pharmaceutical policyUnited States.http://id.loc.gov/authorities/subjects/sh2008109173Pharmaceutical ethicsUnited States.Medicaid fraud.http://id.loc.gov/authorities/subjects/sh85082858Medication abuseUnited States.http://id.loc.gov/authorities/subjects/sh2010101310United States.http://id.nlm.nih.gov/mesh/D01448139015042696529Buhr B 124203100347724520241217201900.020250726000000.020260314165432.02026-03-15T11:29:48Z2024-11-30T18:30:02ZSDR-MIUmiuALMAprepare.pl-004-009BKsdr-miu.990034772450106381MiUSDRMIU003477245mdp.39015042696529MIU990034772450106381MIUMIU20260315googlemdp.390150426965291992pdbibUS fed docPSTPST20260121googlepst.0000212285754.N 16:102-2-101992pdbibUS fed doc